Live
Clinical OMICsHave Microbubbles Burst Through the Barriers of Genetic Medicine Delivery?Clinical OMICsOLE Identified as a Potential Alzheimer’s Therapy Targeting MicrogliaEndpoints NewsFDA gives rejected drugs another chance in post-Makary eraClinical OMICsAI Discovers Two New Antibiotics for Drug-Resistant GonorrheaClinical OMICsGLP-1 Drugs Reduce Crime-Linked BehaviorClinical OMICsMacrophage EGFR Activity Linked to Immune Suppression, Tumor Growth in Colorectal CancerClinical OMICsUnexpected Role for RNA Editing in Cancer Immune Evasion UncoveredClinical OMICsProactive Surveillance Pays Off for Patients with Li-Fraumeni SyndromeClinical OMICsCAR T Success Hinges on Microenvironment Response in GBMEndpoints NewsFDA warns telehealth companies over compounded GLP-1sBioPharma DiveUniQure to file gene therapy for approval, reflecting major shifts at FDABioWorldJazz taps Abcellera in potential $4B antibody discovery deal

Archiv

Aktuell Älteste Löschen
@MACHEREY-NAGEL GmbH & Co. KG
Gesamt 26
Quelle MACHEREY-NAGEL GmbH & Co. KG
Suche --